These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12354364)

  • 1. Interferons as antiangiogenic agents.
    Lindner DJ
    Curr Oncol Rep; 2002 Nov; 4(6):510-4. PubMed ID: 12354364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemangiomas - current therapeutic strategies.
    Mabeta P; Pepper MS
    Int J Dev Biol; 2011; 55(4-5):431-7. PubMed ID: 21858768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide.
    Soni S; Lee DS; DiVito J; Bui AH; DeRaffele G; Radel E; Kaufman HL
    J Pediatr Hematol Oncol; 2002; 24(6):488-91. PubMed ID: 12218599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide in Kaposi sarcoma: promising or disappointing?
    Laffitte E
    Dermatology; 2007; 215(3):171-2. PubMed ID: 17823510
    [No Abstract]   [Full Text] [Related]  

  • 5. The nonsurgical management of vascular lesions.
    Adams DM
    Facial Plast Surg Clin North Am; 2001 Nov; 9(4):601-8. PubMed ID: 17590946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thalidomide combined with interferon and interleukin-2 in treatment of relapsed or refractory acute myelogenous leukemia].
    Wei XD; Ai H; Mi RH; Chen L; Yuan FF; Hao QM; Yin QS; Wang P; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):875-877. PubMed ID: 27801345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of malignant melanoma].
    Avril MF
    Ann Dermatol Venereol; 1988; 115(9):959-68. PubMed ID: 2464963
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
    Du GJ; Lin HH; Xu QT; Wang MW
    Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons and other cytokines in head and neck cancer.
    Hamasaki VK; Vokes EE
    Med Oncol; 1995 Mar; 12(1):23-33. PubMed ID: 8542243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifen.
    Bezwoda WR
    Cancer Treat Rev; 1997 Jan; 23(1):17-34. PubMed ID: 9189179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
    Rajkumar SV; Witzig TE
    Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U; Suciu S; Eggermont AM
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide: dual benefits in palliative medicine and oncology.
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(5):347-51. PubMed ID: 11565189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Bodet-Milin C; Niaudet C; Saï-Maurel C; Moreau A; Faivre-Chauvet A; Thomare P; Deleris G; Estieu-Gionnet K; Bikfalvi A; Barbet J; Paris F
    J Nucl Med; 2010 Apr; 51(4):624-31. PubMed ID: 20351352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
    Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
    Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.
    Lee JI; Itasaka S; Kim JT; Nam DH
    Oncol Rep; 2006 May; 15(5):1163-8. PubMed ID: 16596180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo.
    Vasvari GP; Dyckhoff G; Kashfi F; Lemke B; Lohr J; Helmke BM; Schirrmacher V; Plinkert PK; Beckhove P; Herold-Mende CC
    Int J Cancer; 2007 Oct; 121(8):1697-704. PubMed ID: 17557286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pediatrician's views on the treatment of extensive hemangiomas in childhood].
    Hornová J; Haviar D; Fabriciová K; Tichá L; Horn F; Babala J; Cingel V; Benedeková M
    Rozhl Chir; 2002 Mar; 81(3):138-43. PubMed ID: 11925656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenesis in the treatment of skin cancer.
    Li VW; Li WW
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s17-24. PubMed ID: 18277459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.